Differences

This shows you the differences between two versions of the page.

--- ugli [2026/04/07 14:30] – [Overlap between studies] sylvia
+++ ugli [2026/06/04 09:33] (current) – [Imputation] sylvia
@@ Line 40: / Line 40: @@
 chromosomes passing all QC steps described in {{ :qc_report_ugli1_release_2_-v1.pdf |}} were used for genetic imputation. Genetic imputation was done through the Sanger imputation service
 using the Haplotype Reference Consortium
-( [[http://www.haplotype-reference-consortium.org]] ) panel. The dataset was formatted
+( [[https://www.sanger.ac.uk/collaboration/haplotype-reference-consortium/]] ) panel. The dataset was formatted
 following the instructions from the Sanger webpage
 ( [[https://www.sanger.ac.uk/science/tools/sanger-imputation-service]] ).\\
@@ Line 80: / Line 80: @@
 ====Imputation====
-A final set of 28,149 samples and 460,136 markers on autosomal and X chromosomes passing all QC steps described above were used for genetic imputation. Genetic imputation was done through the Sanger imputation service using the Haplotype Reference Consortium (http://www.haplotype-reference-consortium.org) panel.
+A final set of 28,149 samples and 460,136 markers on autosomal and X chromosomes passing all QC steps described above were used for genetic imputation. Genetic imputation was done through the Sanger imputation service using the Haplotype Reference Consortium (https://www.sanger.ac.uk/collaboration/haplotype-reference-consortium/) panel.
 ====SNP array intensity files====
@@ Line 111: / Line 111: @@
 ====Imputation====
 A final set of 60,157 samples and 476,693 markers on autosomal and X chromosomes passing all QC steps described in the QC rapport and were used for genetic phasing and imputation. Genetic imputation was done through the
-Sanger imputation service using the Haplotype Reference Consortium (http://www.haplotype-reference-consortium.org) panel.
+Sanger imputation service using the Haplotype Reference Consortium (https://www.sanger.ac.uk/collaboration/haplotype-reference-consortium/) panel.
 Method: See QC report
@@ Line 124: / Line 124: @@
 ^ Study name  ^ N in UGLI1  ^ N in UGLI2+3 ^
 | DEEP (DAG1)        | ~600        | ~50 |
+| GoNL (DAG2)        | 143         | |
 | DAG3        | ~8000       | |
-| GoNL        | 143         | |
+Table 2: A number of participants in UGLI also participated in other studies, i.e. [[deep|DAG1]], [[dag2|DAG2]]/[[http://www.nlgenome.nl/|GoNL]] and [[dag3|DAG3]]. In the second and third column the sample sizes that overlap between these studies and UGLI can be found. For more on overlap between studies see [[Omics studies overlap]].
-Table 2: A number of participants in UGLI also participated in other studies, i.e. [[deep|DAG1]], [[dag3|DAG3]], [[dag2|DAG2]]/[[http://www.nlgenome.nl/|GoNL]] and [[gwas|GWAS4]]. In the second and third column the sample sizes that overlap between these studies and UGLI can be found. For more on overlap between studies see [[Omics studies overlap]].
 \\
 \\